Pharmaceuticals prescribed at the expense of the statutory health insurance by ATC-groups (in defined daily doses (DDD) per person insured in the statutory health insurance). Classification: year, Germany, age group, pharmaceutical group (2. ATC level)

ATC-group (2nd level)	Year (descending)
	2006	2010	2015	2016	2017	2018	2019	2020	2021	2022
Overall market of statutory health insurance (GKV) prescriptions with manufactured drugs	418.6	507.2	568.7	574.7	571.1	568.5	600.1	616.9	630.4	645.1
A01 Stomatological preparations	3.2	1.1	6.0	6.3	6.4	5.9	6.5	6.1	6.1	5.8
A02 Ulcer therapeutics	18.7	34.1	53.1	54.6	51.5	49.9	50.8	51.2	52.0	52.1
A03 Spasmolytics	1.2	1.3	0.9	0.9	0.8	0.7	0.7	0.6	0.6	0.6
A04 Antiemetics	0.1	0.1	0.1	-	-	-	-	-	-	-
A05 Gallen-/Lebertherapeutika	-	-	-	0.4	0.4	0.4	0.4	0.4	0.4	0.4
A06 Laxatives	0.8	1.0	1.2	1.3	1.3	1.3	1.3	1.4	1.5	1.4
A07 Antidiarrheals	1.0	1.2	1.4	1.4	1.4	1.4	1.5	1.5	1.5	1.6
A09 Digestiva	-	-	-	-	-	-	-	-	-	0.3
A10 Antidiabetics	24.2	29.7	30.2	30.6	30.6	30.3	31.9	33.2	34.1	36.8
A11 Vitamins	4.3	4.6	7.0	7.5	7.9	8.0	8.1	8.8	9.4	9.3
A12 Minerals	2.0	2.2	1.7	1.6	1.5	1.4	1.5	1.4	1.3	1.2
B01 Antithrombotical agents	14.7	18.5	23.2	23.8	24.0	24.3	26.0	27.0	27.2	27.2
B03 Antianemic combinations	2.3	2.8	3.8	4.1	4.2	4.3	4.5	4.4	4.5	4.6
B05 Blood substitute drugs and       perfusion solutions	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
C01 Cardiac therapeutics	13.0	9.6	6.2	5.7	5.3	4.8	4.7	4.6	4.3	4.2
C02 Antihypertensives	4.6	4.9	5.0	5.0	4.9	4.8	5.1	5.2	5.3	5.3
C03 Diuretics	25.8	28.0	26.5	26.1	25.4	24.7	25.7	26.3	26.0	25.7
C04 Peripheral vasodilators	0.8	-	-	-	-	-	-	-	-	-
C05 Vasoprotectives	0.3	0.3	0.2	-	-	-	-	-	-	-
C07 Beta-receptor blocker	28.2	32.6	31.9	31.2	30.4	29.2	29.7	-	-	28.7
C08 Calcium antagonists	21.7	28.3	30.0	30.5	30.6	30.7	33.4	35.3	36.1	36.7
C09 Angiotensin inhibitor	68.5	104.2	122.5	124.5	125.1	126.2	136.4	142.2	144.8	147.5
C10 Antilipemics	27.2	23.7	28.9	30.7	31.9	33.4	37.4	41.3	45.6	49.5
D01 Antifungals (topical)	1.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.2
D02 Hautschutzmittel	-	-	-	-	-	-	-	0.4	0.4	0.5
D04 Antipruriginous agents	0.4	-	-	-	-	-	-	-	-	-
D05 Antipsoriatika	-	-	-	0.6	0.7	0.7	0.8	0.8	0.8	0.8
D06 Antiinfectives (dermatological)	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.4	0.4	0.4
D07 Corticosteroids (dermatological)	3.6	3.8	4.4	4.5	4.5	4.5	4.7	4.9	5.0	5.0
D10 Anti-acne preparations	0.5	0.6	0.7	0.7	0.7	0.6	0.6	0.7	0.8	0.7
D11 Other dermatological preparations	0.7	0.7	0.9	1.0	1.0	1.1	1.2	1.2	1.2	1.2
G01 Gynaecological antiinfectivs	0.1	0.1	0.1	-	-	-	-	-	-	-
G03 Sexual hormones	16.3	14.7	12.7	12.1	11.6	11.2	12.5	12.9	14.7	14.8
G04 Urological drugs	4.9	7.7	9.2	9.4	9.4	9.5	10.1	10.4	10.7	10.8
H02 Corticosteroids (systemic)	5.1	5.8	6.1	6.1	6.1	6.0	6.2	6.0	5.9	6.0
H03 Thyroids therapeutics	18.9	21.9	25.1	25.2	25.1	24.8	25.7	26.2	25.9	25.9
J01 Antibiotics	4.7	5.1	5.2	5.2	4.6	4.3	4.1	3.3	3.0	3.7
J05 Antivirals	0.4	0.5	0.7	0.6	0.6	0.6	0.7	0.7	0.8	0.8
Vaccines	-	0.0	0.0	0.0	-	-	-	-	-	-
L01 Antineoplastic Agents	-	-	-	-	1.0	0.9	1.0	1.1	1.2	1.2
L02 Hormone antagonists	1.7	2.0	2.0	2.1	2.1	2.1	2.2	2.3	2.3	2.4
L03 Immunostimulants	0.4	0.4	-	0.3	0.3	-	-	-	-	-
L04 Immunosuppressants	1.0	1.2	1.6	1.8	2.0	2.2	2.5	2.7	2.9	3.2
M01 Antiphlogistics/anti-inflammatory       drugs	12.9	15.3	15.7	15.5	14.7	14.3	14.6	14.0	14.2	15.2
M02 Anti-inflammatory agens (topical)	0.3	-	-	-	-	-	-	-	-	-
M03 Muscle relaxants	1.2	1.9	1.6	1.6	2.0	2.1	2.3	2.3	2.5	2.7
M04 Gout agents	5.0	5.2	5.4	5.4	5.3	5.2	5.3	5.2	5.1	4.9
M05 Osteoporosis agents	2.3	3.2	3.0	3.0	2.9	2.9	3.0	3.1	3.1	3.1
M09 Antiarthrotika/andere Mittel	-	-	-	-	-	0.3	0.3	0.3	0.3	0.4
N02 Analgesics	6.9	8.6	9.1	9.3	9.3	9.1	9.5	9.9	10.1	13.0
N03 Antiepileptics	3.4	4.6	5.7	5.8	5.9	5.9	6.4	6.7	6.8	4.4
N04 Anti parkinson drugs	1.8	2.1	2.2	2.2	2.1	2.1	2.2	2.2	2.2	2.1
N05 Psycholeptics	8.2	8.3	7.9	7.7	7.6	7.4	7.6	7.7	7.7	7.6
N06 Psychoanaleptics	13.0	19.4	23.0	23.1	23.2	23.3	24.7	25.6	26.3	27.1
N07 Anti vertiginous and addiction       therapeutics	1.2	1.3	1.6	1.6	1.7	1.6	1.6	1.7	2.0	2.6
R01 Rhinologic drugs	3.5	3.9	4.3	4.3	3.7	3.6	3.7	3.1	3.3	4.1
R03 Anti-asthma medication	16.7	18.3	18.2	18.2	18.1	18.0	19.0	19.4	19.2	19.7
R05 Cough and cold preparations	2.6	2.1	1.6	1.5	1.4	1.3	1.2	0.9	0.9	1.2
R06 Antihistamines	1.6	1.4	1.5	1.6	1.5	1.6	1.7	1.7	1.7	1.7
S01 Ophthalmic drugs	9.4	9.6	10.6	10.8	10.9	10.9	11.5	11.2	11.4	11.8
S02 Otologicals	0.3	0.2	0.2	-	-	-	-	-	-	-
V01 Allergens	-	-	-	1.9	2.0	2.0	2.1	2.3	2.4	2.3

Change table

Table shows following page dimension(s)		New selection:
Dimension	Current dimension value	List of dimension values
Age	All age-groups	All age-groups Under 5 years 5 to under 10 years 10 to under 15 years 15 to under 20 years 20 to under 25 years 25 to under 30 years 30 to under 35 years 35 to under 40 years 40 to under 45 years 45 to under 50 years 50 to under 55 years 55 to under 60 years 60 to under 65 years 65 to under 70 years 70 to under 75 years 75 to under 80 years 80 to under 85 years 85 to under 90 years 90 years and older

Change dimension:	Dimension	Row	Column	Page
	Year
	Age
	ATC-group (2nd level)
The table has 630 cells (63 rows and 10 columns).

Show value selection

  (On the page "Value selection" you can choose for every dimension any dimension value for your selection.)

---

Interactive graphics     Line chart     

Source(s)/Contact

• German Drug Index, AOK Research Institute (WIdO) (more information on 
  Popup
  , more information on 
  Popup
  )

Definition(s)

• Popup

  Popup

Comment(s)

• Only the main drug groups are presented.

Refresh period of data

• The table was extended by the year 2022 on 23 Feb 2024.
  Information for a new reporting period will be added as soon as it is available.

Links

• Information concerning Pharmaceuticals according to Red List, daily dose per insured person .

The Federal Health Monitoring System 17. Apr 2024